TFA Therapeutics (RAJAF) EBITDA (2020 - 2023)
TFA Therapeutics (RAJAF) posted EBITDA of $120448.0 for Q4 2023, up 426.41% on a QoQ basis from -$36901.0 in Q4 2022, and up 426.41% year-over-year from $22881.1 in Q4 2022.
Powered by 
Analysis
TFA Therapeutics (RAJAF) EBITDA (2020 - 2023) Analysis & Trends
TFA Therapeutics has reported EBITDA for 3 years, with the latest figure at $120448.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 1.02 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 699.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 633.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 216.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 23.50 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 128.30 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 25.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 9.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 120,448.00 |
| Dec 31, 2022 | -36,901.00 |
| Dec 31, 2020 | 8,844.00 |